Similarly, MCH has been shown to independently predict OS in patients with gastroesophageal adenocarcinoma, esophageal cancer, and CRC [33,40,50,55], although the prognostic value of MCH in lung cancer is unclear. The gene discussed is PMCH; the disease is esophageal cancer.